Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Hisse Senetlerindeki Sıralama #199
GSK plc, together with its subsidiaries, engages in the creation, discovery,... GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Hisse Fiyatı
$51.99
Piyasa Değeri
$104.42B
Değişim (1 gün)
0.29%
Değişim (1 yıl)
32.49%
Ülke
GB
Ticaret GSK plc (GSK)

Kategori

GSK plc (GSK) için Faaliyet Marjı
March 2026 itibarıyla Faaliyet Marjı TTM: 21.95%
GSK plc şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 21.95%'dir. 2024 yılı sonunda şirketin faaliyet marjı 18.05% idi.
GSK plc için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
Yıl Faaliyet Marjı Değiştir
2026 (TTM) 21.95% 0.00%
2025 21.95% 21.61%
2024 18.05% -21.73%
2023 23.06% 1.18%
2022 22.79% 4.11%
2021 21.89% -8.79%
2020 24.00% 4.08%
2019 23.06% -11.14%
2018 25.95% -1.78%
2017 26.42% 7.88%
2016 24.49% 31.31%
2015 18.65% -12.40%
2014 21.29% -21.58%
2013 27.15% 10.55%
2012 24.56% -11.72%
2011 27.82% 58.61%
2010 17.54% -41.06%
2009 29.76% -6.09%
2008 31.69% -3.44%
2007 32.82% 1.61%
2006 32.30% 7.45%
2005 30.06% 8.83%
2004 27.62% -7.13%
2003 29.74% 13.64%
2002 26.17% -11.94%
2001 29.72% 13.61%
2000 26.16% 0.00%
Benzer şirketler veya rakipler için Faaliyet Marjı
Şirket Faaliyet Marjı Faaliyet Marjı Farkı Ülke
45.56% -97.92%
US
23.28% -98.94%
GB
27.17% -98.76%
US
26.72% -98.78%
US
31.24% -98.58%
CH
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.